FDA Approved: GEODON — Supplemental Application (Viatris Specialty LLC)

View source ↗

Summary

FDA approved a supplemental application for GEODON (ziprasidone mesylate) submitted by Viatris Specialty LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder
• Major Depressive Disorder
• Schizophrenia

Drugs mentioned

• Geodon (Ziprasidone)

Snippet

SUPPL AP for GEODON (ZIPRASIDONE MESYLATE)